Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 38, 2012 - Issue 9
Submit an article Journal homepage
363
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery

Yujie WangDepartment of Chemical Engineering, Tsinghua University, Beijing, P.R. China
,
Guoqiang JiangDepartment of Chemical Engineering, Tsinghua University, Beijing, P.R. ChinaCorrespondence[email protected]
,
Tingting QiuDepartment of Chemical Engineering, Tsinghua University, Beijing, P.R. China
&
Fuxin DingDepartment of Chemical Engineering, Tsinghua University, Beijing, P.R. China
Pages 1039-1046 | Received 12 Jun 2011, Accepted 26 Oct 2011, Published online: 29 Nov 2011

References

  • Arias JL. (2011). Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem, 11:1–17.
  • Liu Y, Miyoshi H, Nakamura M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer, 120:2527–2537.
  • Faraji AH, Wipf P. (2009). Nanoparticles in cellular drug delivery. Bioorg Med Chem, 17:2950–2962.
  • Sinha R, Kim GJ, Nie S, Shin DM. (2006). Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther, 5:1909–1917.
  • Chavanpatil MD, Khdair A, Panyam J. (2006). Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci Nanotechnol, 6:2651–2663.
  • Jiang W, Kim BY, Rutka JT, Chan WC. (2008). Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol, 3:145–150.
  • Decuzzi P, Ferrari M. (2008). The receptor-mediated endocytosis of nonspherical particles. Biophys J, 94:3790–3797.
  • Kasuya T, Kuroda S. (2009). Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances. Expert Opin Drug Deliv, 6:39–52.
  • Fallon RJ, Schwartz AL. (1989). Receptor-mediated delivery of drugs to hepatocytes. Adv Drug Deliv Rev 4:49–63.
  • Wu J, Nantz MH, Zern MA. (2002). Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci, 7:d717–d725.
  • Cho CS, Kobayashi A, Takei R, Ishihara T, Maruyama A, Akaike T. (2001). Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials, 22:45–51.
  • Liang HF, Yang TF, Huang CT, Chen MC, Sung HW. (2005). Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells. J Control Release, 105:213–225.
  • Yoo MK, Kim IY, Kim EM, Jeong HJ, Lee CM, Jeong YY et al. (2007). Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting. J Biomed Biotechnol, 2007:94740.
  • Kobayashi K, Sumitomo H. (1985). Synthesis and functions of polystyrene derivatives having pendant oligosaccharides. Polym J, 17:567–575.
  • Feng SS, Mu L, Win KY, Huang G. (2004). Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem, 11:413–424.
  • Singla AK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm, 235:179–192.
  • Wu L, Tang C, Yin C. (2010). Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm, 36:439–448.
  • Wang X, Li J, Wang Y, Cho KJ, Kim G, Gjyrezi A et al. (2009). HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano, 3:3165–3174.
  • Hua MY, Yang HW, Chuang CK, Tsai RY, Chen WJ, Chuang KL et al. (2010). Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials, 31:7355–7363.
  • Xu Z, Gu W, Huang J, Sui H, Zhou Z, Yang Y et al. (2005). In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm, 288:361–368.
  • Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 82:105–114.
  • Ruckenstein E, Manciu M. (2003). Specific ion effects via ion hydration: II. Double layer interaction. Adv Colloid Interface Sci, 105:177–200.
  • Budhian A, Siegel SJ, Winey KI. (2007). Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm, 336:367–375.
  • Dubernet C. (1995). Thermoanalysis of microspheres. Thermochimica, 248:259–269.
  • Hans ML, Lowman AM. (2002). Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mat Sci 6:319–327.
  • Mu L, Feng SS. (2003). PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res, 20:1864–1872.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.